‌

US Patent 11744797 Rapamycin for the treatment of lymphangioleiomyomatosis

Patent 11744797 was granted and assigned to AI Therapeutics on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Current Assignee

OrphAI Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Henri Lichenstein

Thomas Armer

Jonathan M. Rothberg

Lawrence S. Melvin, Jr.

Date of Patent

September 5, 2023

Patent Application Number

17446249

Date Filed

August 27, 2021

Patent Citations

US Patent 8492110 Anti aging agents and methods to identify them

US Patent 9133279 Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols

US Patent 9248110 Compositions and methods of treating and preventing lung cancer and lymphangioleiomyomatosis

US Patent 9387169 Rapamycin powders for pulmonary delivery

US Patent 10092512 Compositions and methods of making brittle-matrix particles through blister pack freezing

US Patent 10307370 Rapamycin for the treatment of lymphangioleiomyomatosis

US Patent 10307371 Rapamycin for the treatment of lymphangioleiomyomatosis

US Patent 11103449 Inhalable rapamycin formulation for treating age-related conditions

...

Patent Primary Examiner

The present invention relates to methods and compositions for treating lymphangioleiomyomatosis in a human subject in need of such treatment. The methods comprise administering to the subject via inhalation an aerosol composition comprising rapamycin or a prodrug or derivative (including analog) thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11744797 Rapamycin for the treatment of lymphangioleiomyomatosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.